Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function
First Claim
Patent Images
1. A medical device comprising:
- a stent having a generally cylindrical shape comprising an outer surface, an inner surface, a first open end and a second open end;
a controlled-release coating comprising an amphiphilic copolymer and at least one angiotensin-(1-7) (Ang-(1-7)) receptor agonist;
wherein at least one of said inner or outer surfaces are adapted to deliver an effective amount of said at least one Ang-(1-7) receptor agonist to a tissue of a mammal; and
wherein vascular endothelial cell function is improved and/or restenosis is inhibited.
1 Assignment
0 Petitions
Accused Products
Abstract
Medical devices with polymer coatings designed to control the release of angiotensin-(1-7) receptor agonists from medical devices are disclosed. The present application also discloses providing vascular stents with angiotensin-(1-7) receptor agonist-containing controlled-release coatings. Methods for treating or inhibiting post-stent implantation restenosis as well as improving vascular endothelial function in patients are also provided.
32 Citations
28 Claims
-
1. A medical device comprising:
-
a stent having a generally cylindrical shape comprising an outer surface, an inner surface, a first open end and a second open end;
a controlled-release coating comprising an amphiphilic copolymer and at least one angiotensin-(1-7) (Ang-(1-7)) receptor agonist;
wherein at least one of said inner or outer surfaces are adapted to deliver an effective amount of said at least one Ang-(1-7) receptor agonist to a tissue of a mammal; and
wherein vascular endothelial cell function is improved and/or restenosis is inhibited. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A vascular stent for inhibiting restenosis in a mammal comprising:
-
stent having a generally cylindrical shape comprising an outer surface, an inner surface, a first open end and a second open end;
a controlled-release coating comprising a PEG methacrylate-cyclohexyl methacrylate copolymer and an anti-restenotic amount of an Ang-(1-7) receptor agonist peptide having the amino acid sequence of SEQ ID NO. 1; and
a methacrylate copolymer topcoat;
wherein said vascular stent deliver an effective amount of said Ang-(1-7) receptor agonist to a tissue of a mammal; and
wherein vascular endothelial cell function is improved and/or restenosis is inhibited. - View Dependent Claims (11)
-
-
12. A method for inhibiting restenosis in a mammal comprising:
-
providing a vascular stent having a controlled-release coating thereon wherein said coating comprises an amphiphilic copolymer and an effective amount of at least one Ang-(1-7) receptor agonist; and
inhibiting restenosis in said mammal. - View Dependent Claims (13, 14, 15, 16, 17, 18, 19)
-
-
20. A method for improving endothelial cell function in a mammal comprising:
-
providing a vascular stent having a controlled-release coating thereon wherein said coating comprises an amphiphilic copolymer and an effective amount of at least one Ang-(1-7) receptor agonist; and
improving vascular endothelial cell function in said mammal. - View Dependent Claims (21, 22, 23, 24, 25, 26, 27)
-
-
28. A method for treating impaired vascular endothelial cell function in a mammal comprising:
-
implanting a stent having a controlled release coating and an effective amount of Ang-(1-7) disposed on at lease one surface of said medical device at a treatment site in a vessel lumen;
releasing said Ang-(1-7) from said surface of said stent such that vascular endothelial cell function is improved at said treatment site.
-
Specification